VolitionRx: Worst day in 4-1/2 years on stock offering

VolitionRX

09/03/2018 15:37

** Diagnostics company's shares  VNRX.A  dive ~20 pct to
$2.36, biggest intraday pct fall since September 2013 
    ** Offers 3.5 mln shares at $2.40/apiece, will raise about
$8.4 mln  urn:newsml:reuters.com:*:nPn8SqcFha
    ** Intends to use net proceeds for product development,
commercialization & clinical studies
    ** Oppenheimer & Co book-runner and National Securities Corp
a co-manager for the offering
    ** As of March 8, company had 26.5 mln shares outstanding 
    ** Shares down nearly 20 pct YTD

 (Reporting by Shreyashi Sanyal in Bengaluru)
 ((RM: Shreyashi.Sanyal.thomsonreuters.com@reuters.net))